PDF herunterladen
Aktuelle Urol 2013; 44(3): 211-222
DOI: 10.1055/s-0032-1328599
Fortbildung
Georg Thieme Verlag KG Stuttgart · New York

Uroonkologische Nachsorge nach radikaler Nephrektomie und nierenerhaltender Tumorresektion

Follow-up after Radical Nephrectomy and Nephron Sparing Surgery of Kidney Tumors
C. Kories
Klinik für Urologie Bochum, Zentrum für minimal-invasive und robotisch assistierte urologische Chirurgie, Augusta- Kranken-Anstalt gGmbH, Bochum
,
B. Ubrig
Klinik für Urologie Bochum, Zentrum für minimal-invasive und robotisch assistierte urologische Chirurgie, Augusta- Kranken-Anstalt gGmbH, Bochum
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
27. Mai 2013 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Zusammenfassung

Das Nierenzellkarzinom stellt die häufigste Entität aller malignen Nierentumoren (> 90 %) dar. Die internationalen Leilinien sind bezüglich der Tumornachsorge zurzeit unvollständig. Neue Herausforderungen ergeben sich durch die zunehmende Anwendung der nierenerhaltenden Tumorchirurgie. Anhand der bekannten Prognosekriterien lassen sich risikoadaptierte Nachsorgekonzepte verfolgen, die in 3 sinnvolle Risikogruppen stratifiziert sind.

Abstract

Renal cell carcinoma represents more than 90 % of all malignant kidney tumors. International guidelines for follow-up examinations after surgery for kidney tumors are still incomplete. New challenges are arising because of growing use of nephron sparing surgery. According to well-known prognosticators risk-adapted follow-up strategies may be established that are stratified into 3 risk groups.

Key words

Nierentumor - Nierenzellkarzinom - nierenerhaltende Chirurgie - radikale Nephrektomie

Key words

kidney tumor - renal cell carcinoma - nephron sparing surgery - radical nephrectomy
 

  • Literatur

  • 1 Jemal A, Siegel R, Xu J et al. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300
    CrossrefPubMedGoogle Scholar
  • 2 Mathew A, Devesa SS, Fraumeni jr. JF et al. Global increases in kidney cancer incidence, 1973–1992. Eur J Cancer Prev 2002; 11: 171-178
    CrossrefPubMedGoogle Scholar
  • 3 Ljungberg B, Cowan N, Hanbury DC et al. EAU guidelines on renal cell carcinoma – updated version 2010. Eur Urol 2010; 58: 398-406
    CrossrefPubMedGoogle Scholar
  • 4 Frank I, Blute ML, Cheville JC et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003; 170: 2217-2220
    CrossrefPubMedGoogle Scholar
  • 5 Gill IS, Aron M, Gervais DA et al. Clinical practice. Small renal mass. N Engl J Med 2010; 362: 624-634
    CrossrefPubMedGoogle Scholar
  • 6 Chawla SN, Crispen PL, Hanlon AL et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006; 175: 425-431
    CrossrefPubMedGoogle Scholar
  • 7 Lowrance WT, Yee DS, Savage C et al. Complications after radical and partial nephrectomy as a function of age. J Urol 2010; 183: 1725-1730
    CrossrefPubMedGoogle Scholar
  • 8 Smaldone MC, Egleston B, Uzzo RG et al. Does partial nephrectomy result in a durable overall survival benefit in the medicare population?. J Urol 2012; 188: 2089-2094
    CrossrefPubMedGoogle Scholar
  • 9 Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
    CrossrefPubMedGoogle Scholar
  • 10 Childs M, Lohse C, Cheveille J. Radical nephrectomy for benign renal masses is associated with diminished overall survival compared with partial nephrectomy. J Urol 2012; 185 Abstr. 1073
    PubMedGoogle Scholar
  • 11 Chang SL, Cipriano LE, Brunello SM et al. Economic and clinical consequences of new onset post-operative chronic kidney disease following radical and partial nephrectomy in the management of small renal masses. J Urol 2011; 185: e612-e613
    PubMedGoogle Scholar
  • 12 Abouassaly R, Alibhai SM, Tomlinson GA et al. The effect of age on the morbidity of kidney surgery. J Urol 2011; 186: 811-816
    CrossrefPubMedGoogle Scholar
  • 13 MacLennan S, Imamura M, Lapitan MC et al. UCAN Systematic Review Reference Group; EAU Renal Cancer Guideline Panel. Systematic review of oncological outcomes following surgical management of localised renal cancer. European Urology 2012; 61: 972-993
    CrossrefPubMedGoogle Scholar
  • 14 Thompson RH, Frank I, Lohse CM et al. The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study. J Urol 2007; 177: 471-476
    CrossrefPubMedGoogle Scholar
  • 15 Pasticier G, Timsit MO, Badet L et al. Nephron-sparing surgery for renal cell carcinoma: detailed analysis of complications over a 15-year period. Eur Urol 2006; 49: 485-490
    CrossrefPubMedGoogle Scholar
  • 16 Lane BR, Novick AC, Babineau D et al. Comparison of laparoscopic and open partial nephrectomy for tumor in a solitary kidney. J Urol 2008; 179: 847-851 discussion 852
    CrossrefPubMedGoogle Scholar
  • 17 Leibovich BC, Blute ML, Cheville JC et al. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 2004; 171: 1066-1070
    CrossrefPubMedGoogle Scholar
  • 18 Margulis V, Tamboli P, Jacobsohn KM et al. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. BJU Int 2007; 100: 1235-1239
    CrossrefPubMedGoogle Scholar
  • 19 Simmons MN, Weight CJ, Gill IS. Laparoscopic radical versus partial nephrectomy for tumors > 4 cm: intermediate-term oncologic and functional outcomes. Urology 2009; 73: 1077-1082
    CrossrefPubMedGoogle Scholar
  • 20 Patard JJ, Shvarts O, Lam JS et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 2004; 171 (6 Pt 1) 2181-2185 quiz 2435
    CrossrefPubMedGoogle Scholar
  • 21 Thompson RH, Siddiqui S, Lohse CM et al. Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol 2009; 182: 2601-2606
    CrossrefPubMedGoogle Scholar
  • 22 Van Poppel H, Da Pozzo L, Albrecht W et al. European Organization for Research and Treatment of Cancer (EORTC); National Cancer Institute of Canada Clinical Trials Group (NCIC CTG); Southwest Oncology Group (SWOG); Eastern Cooperative Oncology Group (ECOG). A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2007; 51: 1606-1615
    CrossrefPubMedGoogle Scholar
  • 23 Breau RH, Crispen PL, Jimenez RE et al. Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol 2010; 183: 903-908
    CrossrefPubMedGoogle Scholar
  • 24 Bensalah K, Pantuck AJ, Rioux-Leclercq N et al. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol 2010; 57: 466-471
    CrossrefPubMedGoogle Scholar
  • 25 Yossepowitch O, Thompson RH, Leibovich BC et al. Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol 2008; 179: 2158-2163
    CrossrefPubMedGoogle Scholar
  • 26 Sutherland SE, Resnick MI, Maclennan GT et al. Does the size of the surgical margin in partial nephrectomy for renal cell cancer really matter?. J Urol 2002; 167: 61-64
    CrossrefPubMedGoogle Scholar
  • 27 Ani I, Finelli A, Alibhai SM et al. Prevalence and impact on survival of positive surgical margins in partial nephrectomy for renal cell carcinoma: a population-based study. BJU Int 2013; DOI: 10.1111/j.1464-410X.2012.11675.x.
    PubMedGoogle Scholar
  • 28 Dulabon LM, Lowrance WT, Russo P et al. Trends in renal tumor surgery delivery within the United States. Cancer 2010; 116: 2316-2321
    PubMedGoogle Scholar
  • 29 Smaldone MC, Kutikov A, Egleston B et al. Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors. Urology 2012; 80: 286-291
    CrossrefPubMedGoogle Scholar
  • 30 Simone G, Papalia R, Guaglianone S et al. Zero ischemia laparoscopic partial nephrectomy after superselective transarterial tumor embolization for tumors with moderate nephrometry score: long-term results of a single-center experience. J Endourol 2011; 25: 1443-1446
    CrossrefPubMedGoogle Scholar
  • 31 Stevens LA, Coresh J, Feldman HI et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 2007; 18: 2749-2757
    CrossrefPubMedGoogle Scholar
  • 32 Stephenson AJ, Chetner MP, Rourke K et al. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol 2004; 172: 58-62
    CrossrefPubMedGoogle Scholar
  • 33 Master VA, Gottschalk AR, Kane C et al. Management of isolated renal fossa recurrence following radical nephrectomy. J Urol 2005; 174: 473-477 discussion 477
    CrossrefPubMedGoogle Scholar
  • 34 Bruno JJ, Snyder ME, Motzer RJ et al. Renal cell carcinoma local recurrences, impact of surgical treatment and concomitant metastasis on survival. BJU Int 2006; 97: 933-938
    CrossrefPubMedGoogle Scholar
  • 35 Gandhu SS, Symes A, AʼHern R et al. Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma. BJU Int 2005; 95: 522-525
    CrossrefPubMedGoogle Scholar
  • 36 Patard JJ, Shvarts O, Lam JS et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 2004; 171: 2181-2185
    CrossrefPubMedGoogle Scholar
  • 37 Campbell SC, Novick AC, Belldegrun A et al. Guideline for management of the clinical T1 renal mass. J Urol 2009; 182: 1271-1279
    CrossrefPubMedGoogle Scholar
  • 38 Lopez-Costea MA, Fumadó L, Lorente D et al. Positive margins after nephron-sparing surgery for renal cell carcinoma: long-term follow-up of patients on active surveillance. BJU Int 2010; 106: 645-648
    CrossrefPubMedGoogle Scholar
  • 39 Klatte T, Grubmüller B, Waldert M et al. Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studies. Eur Urol 2011; 60: 435-443
    CrossrefPubMedGoogle Scholar
  • 40 Bani-Hani AH, Leibovich BC, Lohse CM et al. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2352 patients. J Urol 2005; 173: 391-394
    CrossrefPubMedGoogle Scholar
  • 41 Janzen NK, Kim HL, Figlin RA et al. Review surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 2003; 30: 843-852
    CrossrefPubMedGoogle Scholar
  • 42 Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med 1996; 335: 865-875
    CrossrefPubMedGoogle Scholar
  • 43 Kontak JA, Campbell SC. Prognostic factors in renal cell carcinoma. Urol Clin North Am 2003; 30: 467-480
    CrossrefPubMedGoogle Scholar
  • 44 Lane BR, Kattan MW. Prognostic models and algorithms in renal cell carcinoma. Urol Clin North Am 2008; 35: 613-625
    CrossrefPubMedGoogle Scholar
  • 45 Ficarra V, Guillè F, Schips L et al. Proposal for revision of the TNM classification system for renal cell carcinoma. Cancer 2005; 104: 2116-2123
    CrossrefPubMedGoogle Scholar
  • 46 Frank I, Blute ML, Leibovich BC et al. pT2 classification for renal cell carcinoma. Can its accuracy be improved?. J Urol 2005; 173: 380-384
    CrossrefPubMedGoogle Scholar
  • 47 Leibovich BC, Cheville JC, Lohse CM et al. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. J Urol 2005; 174: 1759-1763
    CrossrefPubMedGoogle Scholar
  • 48 Thompson RH, Cheville JC, Lohse CM et al. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy. Cancer 2005; 104: 53-60
    CrossrefPubMedGoogle Scholar
  • 49 Nguyen MM, Gill IS. Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality. J Urol 2009; 181: 1020-1027
    CrossrefPubMedGoogle Scholar
  • 50 Thompson RH, Hill JR, Babayev Y et al. Metastatic renal cell carcinoma risk according to tumor size. J Urol 2009; 182: 41-45
    CrossrefPubMedGoogle Scholar
  • 51 Crispen PL, Boorjian SA, Lohse CM et al. Outcomes following partial nephrectomy by tumor size. J Urol 2008; 180: 1912-1917
    CrossrefPubMedGoogle Scholar
  • 52 Rothman J, Egleston B, Wong YN et al. Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis. J Urol 2009; 181: 29-33 discussion 33–34
    PubMedGoogle Scholar
  • 53 Patard JJ, Leray E, Rioux-Leclercq N et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005; 23: 2763-2771
    PubMedGoogle Scholar
  • 54 Guinan P, Stuhldreher D, Frank W et al. Report of 337 patients with renal carcinoma emphasizing 110 with stage IV disease and review of the literature. J Surg Oncol 1997; 64: 295-298
    CrossrefPubMedGoogle Scholar
  • 55 Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009; 373: 1119-1132
    CrossrefPubMedGoogle Scholar
  • 56 Ficarra V, Martignoni G, Maffei N et al. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer 2005; 103: 68-75
    CrossrefPubMedGoogle Scholar
  • 57 Peycelon M, Hupertan V, Comperat E et al. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm. J Urol 2009; 181: 35-41
    PubMedGoogle Scholar
  • 58 Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999; 162: 1930-1933
    CrossrefPubMedGoogle Scholar